Omega-3 PUFA market worth 18.95 Bn USD by 2020

Monday 29 February 2016, Amsterdam

The report, now available on ASDReports, "Omega-3 PUFA Market by Type (DHA, EPA, ALA), Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Infant Formula), Source (Marine, Plant), Sub-source) & Region - Global Forecasts to 2020", The market for Omega-3 PUFA is projected to reach USD 18.95 Billion by 2020, at a CAGR of 13.8%.

The report defines and segments the Omega-3 PUFA market on the basis of various types, applications, sources & sub-sources, and regions, with analyses and projections of the market size of each of these segments in terms of value and volume. It also identifies the driving and restraining factors for the Omega-3 PUFA market with an analysis of the trends and opportunities in the market.

Dietary supplements to dominate the Omega-3 PUFA application market

The dietary supplements has been estimated to lead the market both in terms of value and volume. The infant formula application of Omega-3 PUFA is expected to grow at a comparatively higher CAGR. The infant formula segment is growing due to the scientific evidence proving that Omega-3 fortified infant formula is beneficial for the overall development of infants.

DHA: The most widely used type of Omega-3 PUFA

The DHA segment accounted for the largest share in the Omega-3 PUFA market in terms of value and volume. However, the EPA segment of Omega-3 PUFA is projected to grow at a comparatively higher CAGR. DHA and EPA are harvested from more sustainable resources and are hence both preferred over ALA. Growing research and consumer usage, along with the potential health benefits of DHA to support the body’s natural anti-inflammatory response, which benefits heart health, brain health, mood, and a variety of other conditions are driving the demand for DHA.

Asia-Pacific is projected to be the fastest-growing region in Omega-3 PUFA market

North America region was the largest market for Omega-3 PUFA in 2014. The Asia-Pacific region is projected to be the fastest-growing market for Omega-3 PUFA during the forecast period. The market here is driven by the increasing consumer awareness and growing incidences of chronic diseases such as high blood pressure, cancer, cardiovascular disease, and Alzheimer’s disease. According to the World Health Organization, in 2011, non-communicable diseases (NCDs), primarily cardiovascular diseases, cancers, chronic respiratory diseases and diabetes, were responsible for 63% of all deaths worldwide (36 million out of 57 million global deaths).

Japan dominated the Asia-Pacific market for Omega-3 PUFA owing to the rapidly aging population and the growing incidences of chronic diseases. India is the fastest-growing market in the Asia-Pacific region.

This report studies marketing and development strategies, along with the product portfolio of leading companies. It includes the profiles of leading companies such as Cargill, Incorporated (U.S.), FMC Corporation (U.S.), Croda International PLC (U.K.), Omega Protein Corporation (U.S.), and Royal DSM (The Netherlands). The key players in the market are focusing on new product launches of their facilities and products to strengthen their market hold and their product portfolio.